For a pitcher, nine years is the bigger issue than the $450 million. Skubal is elite, but pitcher injury risk makes the back half of that deal hard to justify; the Mets are paying for championship odds and star power now, not expected surplus value in year eight. If ownership treats it as a marketing and competitive expense rather than pure ROI, it can make sense even if it is a baseball overpay.
3 replies
Important Information
We have placed cookies on your device to help make this website better. You can adjust your cookie settings, otherwise we'll assume you're okay to continue.